Format

Send to

Choose Destination
See comment in PubMed Commons below
Hum Gene Ther. 2016 Feb;27(2):134-47. doi: 10.1089/hum.2015.147.

Let There Be Light: Gene and Cell Therapy for Blindness.

Author information

1
1 Sorbonne Universités, UPMC Université Paris 06, INSERM, CNRS, Institut de la Vision , France .
2
2 Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts , DHU Sight Restore, INSERM-DHOS CIC 1423, France .
3
3 Fondation Ophtalmologique Adolphe de Rothschild, Paris, France .

Abstract

Retinal degenerative diseases are a leading cause of irreversible blindness. Retinal cell death is the main cause of vision loss in genetic disorders such as retinitis pigmentosa, Stargardt disease, and Leber congenital amaurosis, as well as in complex age-related diseases such as age-related macular degeneration. For these blinding conditions, gene and cell therapy approaches offer therapeutic intervention at various disease stages. The present review outlines advances in therapies for retinal degenerative disease, focusing on the progress and challenges in the development and clinical translation of gene and cell therapies. A significant body of preclinical evidence and initial clinical results pave the way for further development of these cutting edge treatments for patients with retinal degenerative disorders.

PMID:
26751519
PMCID:
PMC4779297
DOI:
10.1089/hum.2015.147
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Mary Ann Liebert, Inc. Icon for PubMed Central
    Loading ...
    Support Center